Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease

Philip M. Giffard, Steven Y.C. Tong, Deborah C. Holt, Anna P. Ralph, Bart J. Currie

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)
46 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology